title: Efficient heterologous antigen gene delivery and expression by a replication-attenuated BoHV-4-based vaccine vector.
abstract: Bovine Herpesvirus 4 (BoHV-4) is a gammaherpesvirus belonging to the Rhadinovirus genus and due to its biological characteristics has been proposed as a vaccine vector for veterinary vaccines. Because viral vector-associated risk is a major concern for viral vector applications, attenuation is a desirable feature. Therefore, efforts are directed toward the development of highly attenuated viral vectors. BoHV-4 naturally exhibits limited pathogenicity and a further attenuation, in terms of replication, was obtained by disrupting the late gene encoding the 1.7-kb polyadenylated RNA (L1.7). An L1.7 deleted mutant BoHV-4 (BoHV-4-A-KanaGalKΔL1.7), as well as its revertant (BoHV-4-A-Rev), was generated by homologous recombination from the genome of a BoHV-4 isolate (BoHV-4-A) cloned as a bacterial artificial chromosome (BAC). BoHV-4-A-KanaGalKΔL1.7 showed attenuation in terms of competence to reconstitute infectious virus, viral replication, and plaque size when compared to BoHV-4-A, BoHV-4-A-Rev, and BoHV-4-A-KanaGalKΔTK, a recombinant control virus where the KanaGalK selectable marker was inserted into the thymidine kinase open reading frame. The capability of BoHV-4-A-KanaGalKΔL1.7 to deliver and express a heterologous antigen was investigated by replacing the KanaGalK cassette with a vesicular stomatitis virus glycoprotein (VSVg) expression cassette to generate BoHV-4-A-EF1αVSVgΔL1.7. BoHV-4-A-EF1αVSVgΔL1.7 infected cells robustly expressed VSVg, thus confirming that the replication deficiency resulting from L1.7 disruption did not prevent heterologous gene delivery and expression. Although further work is needed to identify the specific function of the BoHV-4 L1.7 gene, the L1.7 gene may represent an ideal targeting locus for the integration of a heterologous antigen expression cassette, resulting in attenuation of the viral vector.
authors.affiliation: Dipartimento di Scienze Medico-Veterinarie, Università di Parma, via del Taglio 10, 43126 Parma, Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Capocefalo
authors.forename: Carlo
authors.initials: C
authors.lastname: Mangia
authors.forename: Valentina
authors.initials: V
authors.lastname: Franceschi
authors.forename: Sarah
authors.initials: S
authors.lastname: Jacca
authors.forename: Vicky L
authors.initials: VL
authors.lastname: van Santen
authors.forename: Gaetano
authors.initials: G
authors.lastname: Donofrio
mesh_terms: D000818:Animals; D015478:Antigens, Heterophile / Q000235:genetics; D002417:Cattle; D022202:Chromosomes, Artificial, Bacterial; D005822:Genetic Vectors; D026021:Herpesvirus 4, Bovine / Q000235:genetics* / Q000276:immunology / Q000472:pathogenicity; D013937:Thymidine Kinase / Q000235:genetics; D014613:Vaccines, Attenuated / Q000235:genetics; D014614:Vaccines, Synthetic / Q000235:genetics* / Q000276:immunology; D014765:Viral Vaccines / Q000235:genetics* / Q000276:immunology; D014779:Virus Replication / Q000235:genetics
chemical_list: D015478:Antigens, Heterophile; D014613:Vaccines, Attenuated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; D013937:Thymidine Kinase
keywords: Bovine herpesvirus 4; Gene deletion; Non-coding RNA; Recombinant virus; Viral vector